menu ☰
menu ˟

Brachytherapy alone can control intermediate-risk prostate cancer

27 Sep 2016
The addition of external beam therapy to brachytherapy did not significantly extend PFS among men with intermediate-risk prostate cancer, according to the initial report of a phase 3 study presented at the ASTRO Annual Meeting.Thus, radiation treatme...

Click here to view the full article which appeared in Hematology Oncology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.